Literature DB >> 33912901

COVID-19 Outbreaks at Two Construction Sites - New York City, October-November 2020.

Dena Bushman1,2, Jency Sekaran1, Nancy Jeffery1, Caroline Rath1, Joel Ackelsberg1, Don Weiss1, Winfred Wu1, Katherine Van Oss1, Kolthida Johnston1, Jamie Huang1, Umaima Khatun1, Tara Sheikh1, Jennie Sutcliff3, Benjamin Tsoi1.   

Abstract

During October 23-November 16, 2020, the New York City Department of Health and Mental Hygiene investigated COVID-19 outbreaks at two construction sites. Challenges in adhering to the New York State Department of Health "Interim COVID-19 Guidance for Construction" were reported. To minimize outbreaks, jurisdictions should increase tailored outreach to the construction industry emphasizing infection prevention. Published by Oxford University Press for the Infectious Diseases Society of America 2021. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Keywords:  COVID-19; Construction; New York City; SARS-CoV-2

Year:  2021        PMID: 33912901      PMCID: PMC8135504          DOI: 10.1093/cid/ciab312

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  3 in total

1.  COVID-19 test positivity by occupation using the Delphi US COVID-19 trends and impact survey, September-November 2020.

Authors:  Jean M Cox-Ganser; Paul K Henneberger; David N Weissman; Garret Guthrie; Caroline P Groth
Journal:  Am J Ind Med       Date:  2022-07-05       Impact factor: 3.079

2.  Occupational characteristics associated with SARS-CoV-2 infection in the UK Biobank during August-November 2020: a cohort study.

Authors:  Elizabeth L Yanik; Bradley A Evanoff; Ann Marie Dale; Yinjiao Ma; Karen E Walker-Bone
Journal:  BMC Public Health       Date:  2022-10-10       Impact factor: 4.135

3.  Missing science: A scoping study of COVID-19 epidemiological data in the United States.

Authors:  Rajiv Bhatia; Isabella Sledge; Stefan Baral
Journal:  PLoS One       Date:  2022-10-12       Impact factor: 3.752

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.